BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1376255)

  • 1. Non-additive effects of multiple amino acid substitutions on antigen-antibody recognition.
    Mateu MG; Andreu D; Carreño C; Roig X; Cairó JJ; Camarero JA; Giralt E; Domingo E
    Eur J Immunol; 1992 Jun; 22(6):1385-9. PubMed ID: 1376255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus.
    Mateu MG; Andreu D; Domingo E
    Virology; 1995 Jun; 210(1):120-7. PubMed ID: 7793064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
    Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenically profound amino acid substitutions occur during large population passages of foot-and-mouth disease virus.
    Sevilla N; Verdaguer N; Domingo E
    Virology; 1996 Nov; 225(2):400-5. PubMed ID: 8918927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. II. Region S(122-136).
    Pride MW; Thanavala YM; Strick N; Houghten RA; Neurath AR
    Pept Res; 1992; 5(4):217-26. PubMed ID: 1384823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antigenic structure of the foot-and-mouth virus. VI. Functional segments of the immunodominant region of the VP1 protein of foot-and-mouth virus strains O1K and A22].
    Gel'famov VM; Grechaninova LA; Kan ES; Iarov AV; Surovoĭ AIu; Vol'pina OM; Chepurkin AV; Ivanov VT
    Bioorg Khim; 1991 May; 17(5):596-605. PubMed ID: 1722673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus.
    Blanco E; Garcia-Briones M; Sanz-Parra A; Gomes P; De Oliveira E; Valero ML; Andreu D; Ley V; Sobrino F
    J Virol; 2001 Apr; 75(7):3164-74. PubMed ID: 11238843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.
    Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH
    Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
    Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
    Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.
    Mateu MG; Hernández J; Martínez MA; Feigelstock D; Lea S; Pérez JJ; Giralt E; Stuart D; Palma EL; Domingo E
    J Virol; 1994 Mar; 68(3):1407-17. PubMed ID: 8107204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and antigenic site analysis of foot-and-mouth disease virus from pigs and cattle in Korea.
    Oem JK; Lee KN; Cho IS; Kye SJ; Park JY; Park JH; Kim YJ; Joo YS; Song HJ
    J Vet Sci; 2005 Jun; 6(2):117-24. PubMed ID: 15933431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic structure of foot and mouth disease virus type A22 (Indian isolates).
    Tulasiram P; Suryanarayana V
    Indian J Exp Biol; 1998 Jan; 36(1):70-5. PubMed ID: 9536655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a new neutralization epitope on VP7 of human serotype 2 rotavirus and evidence for electropherotype differences caused by single nucleotide substitutions.
    Dunn SJ; Ward RL; McNeal MM; Cross TL; Greenberg HB
    Virology; 1993 Nov; 197(1):397-404. PubMed ID: 7692670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two mechanisms of antigenic diversification of foot-and-mouth disease virus.
    Martínez MA; Hernández J; Piccone ME; Palma EL; Domingo E; Knowles N; Mateu MG
    Virology; 1991 Oct; 184(2):695-706. PubMed ID: 1653494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides.
    Haarmann CM; Schwimmbeck PL; Mertens T; Schultheiss HP; Strauer BE
    Virology; 1994 May; 200(2):381-9. PubMed ID: 7513917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos.
    Zamorano P; Wigdorovitz A; Chaher MT; Fernandez FM; Carrillo C; Marcovecchio FE; Sadir AM; Borca MV
    Virology; 1994 Jun; 201(2):383-7. PubMed ID: 8184548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foot-and-mouth disease virus lacking the VP1 G-H loop: the mutant spectrum uncovers interactions among antigenic sites for fitness gain.
    Baranowski E; Ruiz-Jarabo CM; Lim F; Domingo E
    Virology; 2001 Sep; 288(2):192-202. PubMed ID: 11601891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
    Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
    Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergenic and antigenic determinants of latex allergen Hev b 1: peptide mapping of epitopes recognized by human, murine and rabbit antibodies.
    Chen Z; Van Kampen V; Raulf-Heimsoth M; Baur X
    Clin Exp Allergy; 1996 Apr; 26(4):406-15. PubMed ID: 8732237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.